Weight Loss

eDiets(R) Partners with alli(R) to Launch Specifically Designed Fresh Meal Delivery Program

Published in Medical Letter on the CDC and FDA, March 2nd, 2008

eDiets.com, Inc. (NASDAQ:DIET), leveraging the power of the Internet to bring diet, fitness, and healthy lifestyle solutions to everyone, announced an agreement with GlaxoSmithKline Consumer Healthcare (NYSE:GSK) for eDiets to provide customized meal delivery plans specifically designed for use with the market-leading alli(R) product for weight loss.

alli (orlistat 60mg), the only FDA approved over-the-counter weight loss product, has become an important aid for losing excess weight, with more than 2 million users since its June 2007 launch. With the combination of alli, its weight-loss tools (available at myalli.com) and eDiets' meal delivery, dieters can gain access...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2008-03-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry